ERBB2 and neoplasm: The results of the pooled analysis demonstrated that increased FASN expression was associated with large tumor size (odds ratio [OR], 2.04; 95% CI, 1.04-4.00; P = 0.038), HER2 positivity (OR, 1.53; 95% CI, 1.05-2.23; P = 0.028).